Positivity of HIV, hepatitis B and hepatitis C in patients enrolled in a confidential self-exclusion system of blood donation: A cross-sectional analytical study;Positividad del VIH, la hepatitis B y hepatitis C en pacientes incluidos en un confidencial sistema de exclusión de la donación de sangre: Un estudio transversal analítico

Sao Paulo Medical Journal

Volumn 128, Issue 6, 2010, Pages 320-323

  Kasraian, Leila ^a,c   Tavasoli, Alireza ^b,c  

^a Shiraz Blood Transfusion Organization   (Iran)

^b Pathologist and President of Shiraz Blood Transfusion Organization   (Iran)

^c HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

Author keywords

Bloo; Blood born; Donors; Hepatitis; HIV; Pathogens; Safety

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ARTICLE; BLOOD DONOR; BLOOD SAFETY; CONFIDENTIALITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; FEMALE; HEPATITIS B; HEPATITIS C; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PREVALENCE; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

EID: 79951665501     PISSN: 15163180     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-31802010000600002     Document Type: Article

References (12)

1. Pindyck J, Waldman A, Zang E, et al. Measures to decrease the risk of acquired immunodeficiency syndrome transmission by blood transfusion. Evidence of volunteer blood donor cooperation. Transfusion. 1985;25(1):3-9.
2. Tosti ME, Solinas S, Prati D, et al. An estimate of the current risk of transmitting blood-borne infections through blood transfusion in Italy. Br J Haematol. 2002;117(1):215-9.
3. Stigum H, Bosnes V, Magnus P, Ørjasaeter H. Risk behaviour among blood donors who give blood in order to be tested for the human immunodeficiency virus. Vox Sang. 2001;80(1):24-7.
4. Kasraian L, Torab Jahromi SA; International Conference on AIDS (15th: 2004: Bangkok, Thailand). Surveying the frequency of people who have donated blood for the HIV check up at Shiraz Blood Transfusion Organization In the first half of 2003. Int Conf AIDS. 2004 Jul 11-16; 15: abstract no. C11883. Available from: http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=102277448.html. Accessed in 2010 (Jun 23).
5. Korelitz JJ, Williams AE, Busch MP, et al. Demographic characteristics and prevalence of serologic markers among donors who use the confidential unit exclusion process: the Retrovirus Epidemiology Donor Study. Transfusion. 1994;34(10):870-6.
6. Pastucha L, Andres J, Stangel W. Analyse des Spenderselbstausschlusses (SSA) bei Dauerblutspendern [Analysis of donor self exclusion in repeat blood donors]. Beitr Infusionsther. 1990;26:5-8.
7. Petersen LR, Lackritz E, Lewis WF, et al. The effectiveness of the confidential unit exclusion option. Transfusion. 1994;34(10):865-9.
8. Food and Drug Administration. Department of Health & Human Services. Revised recommendations for the prevention of human immunodeficiency virus (HIV) transmission by blood and blood products. April 23, 1992. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRe gulatoryInformation/OtherRecommendationsforManufacturers/MemorandumtoBlo odEstablishments/UCM062834.pdf. Accessed in 2010 (Jun 23).
9. Dodd RY, Notari EP 4th, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion. 2002;42(8):975-9.
10. Zou S, Notari EP 4th, Musavi F, Dodd RY, ARCNET Study Group. Current impact of the confidential unit exclusion option. Transfusion. 2004;44(5):651-7.
11. Koerner K, Peichl-Hoffmann G, Kubanek B. Vertraulicher Spenderselbstausschluss zur Erhöhung der Sicherheit von Blutpräparaten. [Confidential donor self-exclusion for raising the safely of blood preparations]. Dtsch Med Wochenschr. 1990;115(1):8-11.
12. Chiewsilp P, Kithornpan S, Stabunswadigan S, Iamslip W, Suebsaeng C. Evaluation of donor self exclusion program. Southeast Asian J Trop Med Public Health. 1993;24 Suppl 1:130-2.